(OTC:BIXT) Bioxytran Inc.
Ground Floor Opportunity-Very Small Float
#Stroke #BrainTrauma #TissueRegeneration
Bioxytran, Inc. Pioneers 1st Emergency Stroke Treatment
Stroke 5th Leading Cause of Death of US
Higher Survival Rates can be attributed to Treatment Advances, like Bioxtran’s Emergency Treatment like BXT-25
Regen BioPharma, Inc. (OTCQB:RGBP) (OTCQB:RGBPP)
#health #cancer #clinicaltrials #immunotherapy #autoimmunology #lupus #crohns #ulcerativecolitis
Therapies $ Treatments for:
Repressing Tumors/Unleashing Cancer-Killing Effects Potentially
#health #cancer #research
Regen BioPharma, Inc. Reports Additional New NR2F6 Small Molecule Inhibitors
Research supports work toward new treatments for cancer
Today's Economic Calendar
Morning: Stocks Stabilize Following Monday's Plunge; Mar E-Mini S&Ps Up +0.39%; Jan WTI Crude Oil Down -2.93% To A 1-1/4 Year Low.
U.S. futures are pointing to a slight recovery for Wall Street with the stock market on pace for its worst December since the Great Depression. Aside from signs of slowing growth around the world, drama is setting in as the FOMC begins its two-day meeting on interest rate policy. President Trump took aim again yesterday, stating it was "incredible that with a very strong dollar, virtually no inflation and the outside world blowing up around us... the Fed is even considering yet another rate hike."
Oil tumbled another 4% overnight, dropping for a third consecutive session, as reports of swelling inventories and forecasts of record U.S. and Russian output combined with a sharp selloff in equity markets. OPEC and other oil producers agreed this month to curb production by 1.2M barrels per day, but those cuts won't happen until next month and the amount only represents about 1% of global demand.
Coal consumption is expanding after two years of decline, but miners should brace for another period of sluggish growth. According to the IEA, global coal demand will inch up by just over 1% between 2017 and 2023, as growth in India and other Asian countries offsets a decline in Europe and the U.S. While developed nations are ditching the fossil fuel, emerging economies are using coal to quickly scale up electric power generation.
China cut its holdings of U.S. Treasurys - by $12.5B in October - for a fifth consecutive month, amid a broader decline in foreign demand for U.S. government debt due to a strong dollar. Beijing's Treasury appetite has garnered attention due to its continued trade dispute with Washington, which has contributed to the renminbi falling toward the RMB7 threshold vs. the greenback for the first time since the financial crisis.
"Pre-Christmas delights are not to be expected," declared Ifo chief Clemens Fuest, as German business morale fell for the fourth straight month. Ifo's business climate index slipped to 101.0 in December, the lowest level in more than two years. Trade frictions, risks linked to Brexit, anti-government protests in France and weaker growth in emerging markets are all putting the brakes on a nine-year upswing in Europe’s economic powerhouse.
Latest News 12/18/2018
Latest World Gainers & Losers
Company Price % Change
Data as of 4:00:22pm ET
Key U.S. News:
Nov housing starts (expected -0.2% to 1.226 million, Oct +1.5% to 1.228 million),
FOMC begins 2-day policy meeting.
Notable Russell 2000 earnings reports today include:
FedEx (consensus $3.94)
Darden Restaurants (0.91)
FactSet Research (2.29)
Micron Technology (2.94)
U.S. IPO's scheduled to price today:
Equity conferences during the remainder of this week:
Mar 10-year T-notes (ZNH19 +0-045) this morning were up +6 ticks at a 1-week high.
Mar 10-year T-notes on Monday closed higher on the weaker-than-expected Dec Empire manufacturing index and Dec NAHB housing market index.
T-notes were also supported by increased safe-haven demand with the slump in the S&P 500 to a 14-1/2 month low and by the decline in the 10-year T-note breakeven inflation expectations rate to a 1-1/4 year low.
US & Global Bonds Yield Day Weekly Monthly Yearly Date - After Market
The dollar index (DXY00 -0.31%) this morning was down -0.344 (-0.35%) at a 1-week low
EUR/USD (^EURUSD+0.35%) was up +0.0040 (+0.35%) at a 1-week high
USD/JPY (^USDJPY -0.42%) was down -0.49 (-0.43% at a 1-week low
Dollar Index -0.311 (-0.32%)
EUR/USD +0.0042 (+0.37%)
USD/JPY -0.56 (-0.49%)
The dollar index on Monday closed lower on the sell-off in the S&P 500 to a 14-1/2 month low, which boosted safe-haven demand for the yen and knocked USD/JPY to a 1-week low. The dollar was also undercut by the weaker-than-expected U.S. economic data on Dec Empire manufacturing and the Dec NAHB housing market index, which was dovish for Fed policy.
World Currencies -Market Pricing
Latest December 18th
United Kingdom Pound
Data as of 4:09pm ET
Metals prices this morning were mixed
Feb gold (GCG19 +0.02%) +1.4 (+0.11%)
Mar silver (SIH19 -0.37%) -0.019 (-0.13%)
Mar copper (HGH19 -1.56%) -0.042 (-1.52%) at a 1-month low
Feb Comex gold (GCG19) on Monday closed up +10.4 (+0.84%)
Mar Comex silver (SIH19) closed up +0.122 (+0.83%)
A weaker dollar pushed metals prices higher Monday along with a selloff in stocks. The S&P 500 tumbled to a 10-1/4 month low Monday, which boosted safe-haven demand for gold.
Recent stock market turmoil has been a bullish factor for gold on increased demand for gold as a store of wealth after long gold positions in ETFs rose to a 4-1/2 month high last Friday.
On the negative side for silver is weaker-than-expected U.S. economic data that signals reduced demand for industrial metals after Monday's Dec Empire manufacturing index dropped to a 1-1/2 year low and the Dec NAHB housing market index plunged to a 3-1/2 year low.
Also, fund selling of silver continues as long silver positions in ETFs fell to a 5-1/2 month low last Friday.
A negative factor for gold is reduced inflation expectations, which curbs demand for gold as an inflation hedge, after the 10-year T-note inflation expectations rate sank to a 1-1/4 year low.
Jan WTI crude oil prices (CLF19 -2.81%) this morning were down -$1.46 per barrel (-2.93%) at a 1-1/4 year low
Jan gasoline (RBF19 -2.32%) was down -3.38 cents per gallon (-2.40%) at a 2-week low
Jan WTI crude oil (CLF19) on Monday closed down by -$1.32 per barrel (-2.58%)
Feb Brent crude (CBG19) closed down -$0.67 (-1.11%)
Jan RBOB gasoline (RBF19) closed down by -2.39 cents per gallon (-1.67%)
Crude oil gave up an early rally Monday and sold off to a 2-week low on signs of increased global production and suspect energy demand.
Russian oil crude output is on the rise after Interfax reported that Russian December crude production rose by +60,000 bpd to 11.43 million bpd from November's level.
Also, a slump in the S&P 500 to a 14-1/2 month low Monday undercut confidence in the economic outlook and in energy demand.
Crude prices opened higher Monday on the lower dollar and on positive carry-over from last Friday's data from Baker Hughes that showed active U.S. oil rigs in the week ended December 14 fell by -4 rigs to a 1-3/4 month low of 873 rigs.
Norfolk Southern (NSC -2.19%) was upgraded to 'Overweight' from 'Neutral' at JPMorgan Chase with a price target of $203.
CVS Health (CVS -1.66%) was rated a new 'Overweight' at Barclays with a price target of $91.
Boeing (BA -0.82%) gained more than 1% in after-hours trading after it boosted its share buyback plan by $2 billion to $20 billion from $18 billion and boosted its quarterly dividend to $2.055 per share from $1.71 per share.
Johnson & Johnson (JNJ -2.90%) rose nearly 1% in after-hours trading after it said it will buy back as much as $5 billion of its own stock.
Abbott Laboratories (ABT -1.43%) was rated a new 'Outperform' at Credit Suisse with a price target of $82.
HealthEquity (HQY -3.96%) was upgraded to 'Overweight' from 'Neutral' at Cantor Fitzgerald with a price target of $82.
Edwards Lifesciences (EW -3.19%) was rated a new 'Outperform' at Credit Suisse with a price target of $188.
Oracle (ORCL -1.87%) gained more than 1% in after-hours trading after it reported Q2 adjusted EPS of 80 cents, better than consensus of 78 cents.
EOG Resources (EOG -3.87%) was rated a new 'Buy' at SunTrust Robinson Humphrey with a price target of $130.
Boston Scientific (BSX -4.89%) was rated a new 'Outperform' at Credit Suisse with a price target of $42.
Marathon Oil (MRO -2.13%) was rated a new 'Buy' at SunTrust Robinson Humphrey with a price target of $25.
Puma Biotechnology (PBYI -5.14%) climbed more than 5% in after-hours trading after it reported positive results in its Phase III trial of its Neratinib in patients with metastatic breast cancer.